News for NeuroPace, Inc. (NPCE)

PR NewswireNEW YORK, June 1, 2025 NEW YORK, June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeuroPace, Inc. (

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

California-based Bolt Projects Holdings, Inc. (BSLK) is up over 114 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NeuroPace, Inc. (”œNeuroPace” or the ”œCompany

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

U.S. stocks traded higher midway through trading, with the Dow Jones index jumping more than 600 points on Tuesday. President Donald Trump announced the extensi...

NeuroPace (NPCE) has announced preliminary findings from its NAUTILUS study, evaluating the safety and efficacy of its RNS system for patients with idiopathic g

U.S. stocks traded higher this morning, with the Nasdaq Composite surging more than 300 points on Tuesday. President Donald Trump announced the extension of the...

-- NeuroPace has completed the primary endpoint analysis of the one-year data from the first and only clinical study to evaluate neuromodulation therapy for idi

**media[637932]**

U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Wednesday. Shares of Tower Semiconductor Ltd. TSEM rose sharply during Wednesda...

-- Minimal expected impact to operations and financial results -- -- Company to report first quarter 2025 financial results on May 13, 2025 -- MOUNTAIN VIEW,

NeuroPace (NPCE) has announced that despite the recent implementation of tariffs, it foresees negligible effects on its operations and financial performance. Th

**media[594888]**

U.S. stock futures were lower this morning, with the Dow futures falling more than 600 points on Wednesday. Shares of Kura Sushi USA Inc KRUS fell sharply in t...

Three-year data from NeuroPace's Post-Approval Study of the RNS® System in drug-resistant focal epilepsy to be shared in oral presentation MOUNTAIN VIEW, Cal

**media[584958]**

-- Beginning of Wind Down of Stereo EEG (SEEG) Distribution Relationship in Q4 2025 -- -- Maintaining 2025 Revenue Guidance -- -- No Change to Long-Range Plan

**media[584438]**